BIOND Solutions
Bi/ond is a biotechnology startup dedicated to empowering biological innovation through engineering microchips that nourish, stimulate, and monitor cells. Their mission is to improve medical treatments by providing innovative hardware solutions for biomedical research, reflecting human diversity. They develop organ-on-chip technology that recreates key aspects of human organs, aiding research and drug development, and collaborating with top European hospitals and research centers. Bi/ond is also committed to the 3Rs principles, promoting animal-free research alternatives.
Industries
Nr. of Employees
small (1-50)
Patents
Versatile 3D stretchable micro-environment for organ-on-chip devices fabricated with standard silicon technology
US-11565250-B2
View Details
Versatile 3D stretchable micro-environment for organ-on-chip devices fabricated with standard silicon technology
US-11565250-B2
View DetailsProducts
Organ-on-chip microfluidic platform for complex 3D tissues
A microfluidic chip platform that nourishes, stimulates, and monitors complex 3D tissues, intended for organoid, ex vivo tissue, spheroid, and microtissue culture and functional assays.
Muscle-focused microphysiological chip with integrated stimulation and readout
A microfluidic device and complementary plate designed specifically for culturing muscle microtissues with integrated electrodes for electrical stimulation and functional contraction monitoring.
Smart well-plate complement for microfluidic chips
A smart multiwell plate designed to operate with microfluidic chips to nourish, stimulate, and monitor 3D tissues in a standardized plate format.
Organ-on-chip microfluidic platform for complex 3D tissues
A microfluidic chip platform that nourishes, stimulates, and monitors complex 3D tissues, intended for organoid, ex vivo tissue, spheroid, and microtissue culture and functional assays.
Muscle-focused microphysiological chip with integrated stimulation and readout
A microfluidic device and complementary plate designed specifically for culturing muscle microtissues with integrated electrodes for electrical stimulation and functional contraction monitoring.
Smart well-plate complement for microfluidic chips
A smart multiwell plate designed to operate with microfluidic chips to nourish, stimulate, and monitor 3D tissues in a standardized plate format.
Services
Provision of microfluidic hardware, engineering assistance, and protocol development to academic labs, hospitals, and industry partners for organ-on-chip experiments.
Contribution of hardware, assay development, and biological expertise to multi-partner projects funded by Horizon Europe, Eurostars, UKRI and national programs.
Provision of microfluidic hardware, engineering assistance, and protocol development to academic labs, hospitals, and industry partners for organ-on-chip experiments.
Contribution of hardware, assay development, and biological expertise to multi-partner projects funded by Horizon Europe, Eurostars, UKRI and national programs.
Expertise Areas
- Organ-on-chip platform development
- Microfluidics and perfusion engineering
- 3D tissue culture and organoid models
- Muscle-on-chip and neuromuscular disease modeling
Key Technologies
- Microfluidics
- Microfabrication (silicon/polymer processing)
- Integrated electronics and microchips
- On-chip electrodes and electrophysiology
News & Updates
Bi/ond will participate in the Dutch NXTGEN HIGHTECH program supporting high-tech innovations in the Netherlands.
Bi/ond joins the MAGIC project to develop advanced models and gene therapies for neuromuscular diseases.
The company has raised over $4 million through European research and venture investments to advance organ-on-chip technology.
Bi/ond is featured in industry magazine discussing its mission to bridge biology and engineering for personalized treatments.
Cinzia Silvestri, CEO and co-founder, was recognized as a leading woman in tech in Italy.
Nikolas Gaio received the Young Researcher Award for work on replacing animal tests with silicon chips.
Bi/ond will participate in the Dutch NXTGEN HIGHTECH program supporting high-tech innovations in the Netherlands.
Bi/ond joins the MAGIC project to develop advanced models and gene therapies for neuromuscular diseases.
The company has raised over $4 million through European research and venture investments to advance organ-on-chip technology.
Bi/ond is featured in industry magazine discussing its mission to bridge biology and engineering for personalized treatments.
Cinzia Silvestri, CEO and co-founder, was recognized as a leading woman in tech in Italy.
Nikolas Gaio received the Young Researcher Award for work on replacing animal tests with silicon chips.